15 September 2022 • 1 minute read
AI risk assessments: Future-proofing your innovation when rules can change mid-game
Published in Chambers Expert Focus
In this episode, DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.
